Opyl Ltd (OPL) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Opyl Ltd (OPL) has a cash flow conversion efficiency ratio of 1.994x as of December 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-619.98K ≈ $-438.67K USD) by net assets (AU$-310.99K ≈ $-220.05K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See net asset quality index of Opyl Ltd to measure how much of total assets are equity-financed.
Opyl Ltd - Cash Flow Conversion Efficiency Trend (1996–2024)
This chart illustrates how Opyl Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check OPL cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Opyl Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Opyl Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
DTCOM - Direct to Company S.A
SA:DTCY3
|
-3.060x |
|
Project Planning Service Public Company Limited
BK:PPS
|
-0.045x |
|
APB Resources Bhd
KLSE:5568
|
-0.005x |
|
Whitebark Energy Ltd
AU:WBE
|
0.308x |
|
Baillie Gifford Shin Nippon PLC
LSE:BGS
|
0.006x |
|
THOR MNG CUFS/1LS- 00001
F:T5MB
|
N/A |
|
COINSILIUM GROUP LTD
F:5CT
|
N/A |
|
Salarius Pharmaceuticals Inc
NASDAQ:SLRX
|
-0.388x |
Annual Cash Flow Conversion Efficiency for Opyl Ltd (1996–2024)
The table below shows the annual cash flow conversion efficiency of Opyl Ltd from 1996 to 2024. For the full company profile with market capitalisation and key ratios, see OPL market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-06-30 | AU$-90.16K ≈ $-63.79K |
AU$-2.06 Million ≈ $-1.46 Million |
22.811x | +574.80% |
| 2023-06-30 | AU$-403.59K ≈ $-285.56K |
AU$-1.36 Million ≈ $-965.34K |
3.380x | +159.40% |
| 2022-06-30 | AU$267.01K ≈ $188.93K |
AU$-1.52 Million ≈ $-1.08 Million |
-5.691x | -1277.78% |
| 2021-06-30 | AU$2.19 Million ≈ $1.55 Million |
AU$-903.65K ≈ $-639.39K |
-0.413x | +71.13% |
| 2020-06-30 | AU$719.18K ≈ $508.86K |
AU$-1.03 Million ≈ $-728.08K |
-1.431x | -127.41% |
| 2019-06-30 | AU$-402.81K ≈ $-285.01K |
AU$-2.10 Million ≈ $-1.49 Million |
5.221x | +354.11% |
| 2018-06-30 | AU$1.39 Million ≈ $986.43K |
AU$-2.86 Million ≈ $-2.03 Million |
-2.054x | +83.53% |
| 2017-06-30 | AU$230.83K ≈ $163.32K |
AU$-2.88 Million ≈ $-2.04 Million |
-12.471x | -787.81% |
| 2016-06-30 | AU$2.22 Million ≈ $1.57 Million |
AU$-3.12 Million ≈ $-2.20 Million |
-1.405x | -377.56% |
| 2015-06-30 | AU$1.33 Million ≈ $937.83K |
AU$-389.85K ≈ $-275.85K |
-0.294x | -2234.34% |
| 2014-06-30 | AU$5.77 Million ≈ $4.09 Million |
AU$-72.76K ≈ $-51.48K |
-0.013x | +58.48% |
| 2013-06-30 | AU$8.31 Million ≈ $5.88 Million |
AU$-252.29K ≈ $-178.51K |
-0.030x | -110.59% |
| 2012-06-30 | AU$10.12 Million ≈ $7.16 Million |
AU$-145.87K ≈ $-103.21K |
-0.014x | +40.22% |
| 2011-06-30 | AU$14.17 Million ≈ $10.02 Million |
AU$-341.50K ≈ $-241.63K |
-0.024x | +96.37% |
| 2010-06-30 | AU$1.69 Million ≈ $1.19 Million |
AU$-1.12 Million ≈ $-793.50K |
-0.664x | -182.04% |
| 2009-06-30 | AU$-4.04 Million ≈ $-2.86 Million |
AU$-3.27 Million ≈ $-2.31 Million |
0.810x | +4568.99% |
| 2008-06-30 | AU$69.38 Million ≈ $49.09 Million |
AU$-1.26 Million ≈ $-889.41K |
-0.018x | +57.21% |
| 2007-06-30 | AU$59.61 Million ≈ $42.18 Million |
AU$-2.52 Million ≈ $-1.79 Million |
-0.042x | -41.86% |
| 2006-06-30 | AU$52.13 Million ≈ $36.89 Million |
AU$-1.56 Million ≈ $-1.10 Million |
-0.030x | +70.01% |
| 2005-06-30 | AU$13.41 Million ≈ $9.49 Million |
AU$-1.33 Million ≈ $-944.26K |
-0.100x | -367.82% |
| 2004-06-30 | AU$16.09 Million ≈ $11.38 Million |
AU$-342.24K ≈ $-242.16K |
-0.021x | +41.20% |
| 2003-06-30 | AU$10.47 Million ≈ $7.41 Million |
AU$-378.80K ≈ $-268.03K |
-0.036x | -20.83% |
| 2002-06-30 | AU$9.85 Million ≈ $6.97 Million |
AU$-294.88K ≈ $-208.64K |
-0.030x | +44.96% |
| 2001-06-30 | AU$8.89 Million ≈ $6.29 Million |
AU$-483.84K ≈ $-342.34K |
-0.054x | +36.89% |
| 2000-06-30 | AU$9.41 Million ≈ $6.66 Million |
AU$-811.63K ≈ $-574.28K |
-0.086x | -99.74% |
| 1999-06-30 | AU$6.41 Million ≈ $4.53 Million |
AU$-276.48K ≈ $-195.63K |
-0.043x | +7.67% |
| 1998-06-30 | AU$6.42 Million ≈ $4.54 Million |
AU$-299.97K ≈ $-212.25K |
-0.047x | +41.37% |
| 1997-06-30 | AU$6.21 Million ≈ $4.39 Million |
AU$-495.03K ≈ $-350.27K |
-0.080x | +53.83% |
| 1996-06-30 | AU$6.15 Million ≈ $4.35 Million |
AU$-1.06 Million ≈ $-751.81K |
-0.173x | -- |
About Opyl Ltd
Pathkey.AI Ltd engages in the development of digital tools that enhance healthcare experience for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs for pharmaceuticals, medical devices, alternative therapies, and novel conditions. It also provides TrialGen, an AI-powered tool strea… Read more